Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 63.1
(1.25%)
CNY 63.1
(1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 688.18 Million | 91.62 Million | 29.29 Million | -196.74 Million | -259.37 Million | -97.25 Million |
| Net Income | 644.17 Million | 130.52 Million | 18.27 Million | -310.51 Million | -397.5 Million | -97.39 Million |
| Depreciation & Amortization | 40.18 Million | 25.25 Million | 23.46 Million | 11.86 Million | 9.53 Million | 5.04 Million |
| Deferred income taxes | -4.87 Million | -11.5 Million | -97.71 Million | -23.64 Million | -17.48 Million | - |
| Stock-based compensation | 75.03 Million | 68.91 Million | 73.68 Million | 71.61 Million | 201.19 Million | - |
| Change in working capital | -10.57 Million | -63.31 Million | 6.76 Million | 52.17 Million | -62.29 Million | 4.71 Million |
| Other non-cash items | 110.21 Million | -58.23 Million | 4.81 Million | 1.76 Million | 7.16 Million | -9.61 Million |
| Investing Cash Flow | 79.21 Million | -404.21 Million | 239.18 Million | -1.74 Billion | -622.42 Million | 39.16 Million |
| Investments in PPE | -67.88 Million | -143.83 Million | -192.24 Million | -88.45 Million | -89.36 Million | -35.98 Million |
| Acquisitions | - | 3829.00 | -0.33 | 4.47 Billion | - | 0.24 |
| Investment purchases | - | -6.58 Billion | -12.55 Thousand | -4.47 Billion | - | -29.71 Million |
| Sales/Maturities of investments | 272.32 Million | 41.9 Million | 66.8 Million | 23.63 Million | 11.32 Million | 110.48 Million |
| Other Investing Activities | -125.23 Million | 6.27 Billion | 364.63 Million | -1.67 Billion | -544.38 Million | -5.61 Million |
| Financing Cash Flow | -2.2 Million | -3.68 Million | -16.96 Million | 1.91 Billion | 1.15 Billion | 122.14 Million |
| Debt repayment | -2.58 Million | -4.87 Million | -8.96 Million | -110 Million | -35 Million | -60 Million |
| Dividends payments | - | - | - | -1.19 Million | -33.38 Million | -4.5 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 373.91 Thousand | 1.18 Million | -7.99 Million | 2.02 Billion | 1.22 Billion | 186.64 Million |
| Accounts receivables | -163.83 Million | -108.57 Million | 8.21 Million | -1.3 Million | -38.57 Million | -4.79 Million |
| Accounts payables | 184.14 Million | 67.37 Million | 10.88 Million | 64 Million | -23.5 Million | 9.51 Million |
| Inventory | -30.87 Million | -10.62 Million | -12.33 Million | -10.53 Million | -210.5 Thousand | -9557.92 |
| Other working capital | 75.03 Million | -11.5 Million | 0.52 | -0.46 | 24.48 | 4.72 Million |
| Cash at beginning of period | 470.49 Million | 613.97 Million | 365.84 Million | 392.58 Million | 122.99 Million | 58.93 Million |
| Cash at end of period | 1.86 Billion | 314.87 Million | 613.97 Million | 365.84 Million | 392.58 Million | 122.99 Million |
| Capital Expenditure | -67.88 Million | -143.83 Million | -192.24 Million | -88.45 Million | -89.36 Million | -35.98 Million |
| Effect of forex changes on cash | 4.35 Million | 17.16 Million | -3.37 Million | -345.22 Thousand | -1.09 Million | 0.75 |
| Net cash flow / Change in cash | 1.39 Billion | -299.1 Million | 248.13 Million | -26.73 Million | 269.58 Million | 64.05 Million |
| Free Cash Flow | 620.3 Million | -52.2 Million | -162.95 Million | -285.19 Million | -348.74 Million | -133.23 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 406.81 Million | 350.08 Million | 306.05 Million | 644.17 Million | 233.74 Million | 202.01 Million |
| Depreciation & Amortization | - | 9.97 Million | 9.97 Million | 40.18 Million | 9.94 Million | 9.94 Million |
| Deferred income taxes | - | - | - | -4.87 Million | - | - |
| Stock-based compensation | - | 33.9 Million | - | 75.03 Million | 75.03 Million | - |
| Change in working capital | - | -53.16 Million | - | -10.57 Million | -119.68 Million | - |
| Other non-cash items | 105.33 Million | 40.63 Million | 94.25 Million | 110.21 Million | -29.35 Million | 74.38 Million |
| Investing Cash Flow | -175.72 Million | -1.86 Billion | 433.67 Million | 79.21 Million | -97.62 Million | 239.03 Million |
| Investments in PPE | -179.52 Million | -7.64 Million | -46.9 Million | -67.88 Million | 4.02 Million | -5.48 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | 661.24 Million | -661.24 Million | - | - | - | - |
| Sales/Maturities of investments | 5.92 Million | 1.17 Billion | 35.05 Million | 272.32 Million | 272.32 Million | 6.64 Million |
| Other Investing Activities | -2.12 Million | -2.36 Billion | 480.57 Million | -125.23 Million | -373.97 Million | 237.87 Million |
| Financing Cash Flow | -113.36 Million | -180.52 Million | -841.22 Thousand | -2.2 Million | -13.92 Thousand | -756.59 Thousand |
| Debt repayment | - | - | - | -2.58 Million | - | - |
| Dividends payments | -112.5 Million | -179.99 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -868.54 Thousand | -179.24 Million | -841.22 Thousand | 373.91 Thousand | 2.56 Million | -756.59 Thousand |
| Accounts receivables | - | -76.91 Million | - | -163.83 Million | -163.83 Million | - |
| Accounts payables | - | - | - | 184.14 Million | - | - |
| Inventory | - | 23.75 Million | - | -30.87 Million | -30.87 Million | - |
| Other working capital | - | - | - | 75.03 Million | 75.03 Million | - |
| Cash at beginning of period | 257.56 Million | 2.39 Billion | 1.86 Billion | 470.49 Million | 1.46 Billion | 475.16 Million |
| Cash at end of period | 474.69 Million | 462.94 Million | 2.39 Billion | 1.86 Billion | 1.86 Billion | 988.98 Million |
| Capital Expenditure | -179.52 Million | -7.64 Million | -46.9 Million | -67.88 Million | 4.02 Million | -5.48 Million |
| Effect of forex changes on cash | -2393.39 | 9783.44 | 1686.82 | 4.35 Million | -1.36 Million | -861.88 Thousand |
| Net cash flow / Change in cash | 217.12 Million | -1.93 Billion | 535.51 Million | 1.39 Billion | 393.06 Million | 513.81 Million |
| Free Cash Flow | 332.62 Million | 373.08 Million | 353.4 Million | 620.3 Million | 198.46 Million | 270.91 Million |
ALTF
VUL
CRPHY
6538
8544
QBE